[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-360309-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-360309-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","trim29-promotes-pancreatic-cancer-mvi-via-ib-k48-ubiquitination-and-nf-b-activation-in-cxcl5-epithelial-cells","TRIM29 promotes pancreatic cancer - MVI via IκBα K48-ubiquitination and NF-κB activation in CXCL5⁺ epithelial cells","","Purpose and scope: investigate how microvascular invasion (MVI) influences metastasis and poor prognosis of pancreatic ductal adenocarcinoma (PDAC) through tumor microenvironment mechanisms. Methods: an integrative multi-omics strategy combines spatial proteomics, transcriptome sequencing, and single-cell RNA-seq to profile MVI⁺ vs MVI⁻ PDAC, supported by functional in vitro/in vivo assays and Co-IP, ubiquitination, and ChIP-qPCR. Results: EMT is activated in MVI⁺ tumors, driven by a CXCL5 epithelial subset and ZBTB7B-dependent TRIM29-mediated K48 ubiquitination and degradation of IκBα, activating NF-κB and worsening invasion, metastasis, and clinical outcomes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/trim29-promotes-pancreatic-cancer-mvi-via-ib-k48-ubiquitination-and-nf-b-activation-in-cxcl5-epithelial-cells/360309/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/trim29-promotes-pancreatic-cancer-mvi-via-ib-k48-ubiquitination-and-nf-b-activation-in-cxcl5-epithelial-cells/360309.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the main mechanism proposed connecting MVI to EMT in PDAC?","Question",{"text":63,"@type":64},"In MVI⁺ tumors, ZBTB7B promotes TRIM29 transcription, and TRIM29 ubiquitinates IκBα via K48-linked modification, leading to proteasomal degradation. This activates NF-κB signaling and induces EMT, enhancing invasion and metastasis.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which cell population is highlighted as important for MVI-associated EMT?",{"text":68,"@type":64},"Single-cell RNA-seq identifies a CXCL5-expressing epithelial subpopulation characterized by a strong EMT phenotype, enriched in MVI⁺ samples and positioned closer to microvessels.",{"name":70,"@type":61,"acceptedAnswer":71},"How do TRIM29 and IκBα relate to patient prognosis in this study?",{"text":72,"@type":64},"Clinical correlation analysis shows a significant negative correlation between TRIM29 and IκBα protein levels. High TRIM29 with low IκBα and high CXCL5⁺ EMT levels associates with poor prognosis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},360309,1790982602,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":33,"preview_urls":144},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Liu et al. Molecular Cancer (2026) 25:145 Molecular Cancer  \n[https://doi.org/10.1186/s12943-026-02652-3](https://doi.org/10.1186/s12943-026-02652-3)  \nRESEARCH Open Access  \nTRIM29 promotes pancreatic cancer MVI via  IκBα K48-ubiquitination and NF-κB activation in CXCL5 ⁺ epithelial cells  \nLong Liu1,2,3†, Zhenzhen Gao2†, Qi Wang1†, Xiaohong Zhao4, Fabiao Zhang1, Yu Zhu1, Wangyang Sun5, Yuxi Huang1, Zhenbo Wang6, Sheng Yan2*, Shaowei Li7,8* andYu Zhang9,10*  \nAbstract  \nPurpose To investigate the mechanisms underlying the interaction and influence between microvascular invasion (MVI), which contributes to metastasis and poor prognosis of pancreatic ductal adenocarcinoma (PDAC), and tumor microenvironment.  \nMethods This study employed an integrative multi-omics approach, combining spatial proteomics (multiplex immunofluorescence), transcriptome sequencing, and single-cell RNA sequencing (scRNA-seq) to profile MVI⁺ and MVI ⁻ PDAC samples. The functional role of key genes was validated through in vitro and in vivo assays (migration, invasion, xenograft models) . Molecular mechanisms were dissected using Co-IP, ubiquitination assays, and ChIP-qPCR. Results The epithelial-mesenchymal transition (EMT) process was significantly activated in MVI⁺ tumors, with  \nEMT-positive cells located spatially closer to microvessels. scRNA-seq identified a distinct epithelial subpopulation characterized by CXCL5 that exhibited a strong EMT phenotype and was enriched in MVI⁺ samples. Mechanistically, the transcription factor ZBTB7B was found to directly promote TRIM29 transcription. TRIM29 directly binds to IκBα via its BB2 domain and catalyzes its K48-linked ubiquitination and proteasomal degradation. This event relieves the inhibition of the NF-κB signaling pathway, leading to its activation and the subsequent induction of EMT, ultimately enhancing the invasive and metastatic capabilities of pancreatic cancer cells. Clinical correlation analysis revealed a significant negative correlation between TRIM29 and IκBα protein levels, and high TRIM29, low IκBα, and high CXCL5⁺ EMT levels were all associated with poor prognosis.  \n†Long Liu, Zhenzhen Gao and Qi Wang contributed equally to this work.  \n*Correspondence:  \nSheng Yan [shengyan@zju.edu.cn](shengyan@zju.edu.cn)[ ](shengyan@zju.edu.cn)Shaowei Li[li_shaowei81@hotmail.com](li_shaowei81@hotmail.com)[ ](li_shaowei81@hotmail.com)Yu Zhang [zhangyu199831@163.com](zhangyu199831@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nConclusion This study reveals the critical role of the ZBTB7B-TRIM29-IκBα-NF-κB signaling axis in promoting EMTin CXCL5-marked pancreatic cancer cells surrounding MVI, establishing TRIM29 as a potential therapeutic target for inhibiting early metastasis of PDAC.  \nClinical relevance This study provides deep insights into","cbCainQdNYfmqzg1","https://ap.wps.com/l/cbCainQdNYfmqzg1","pdf",16031417,"English","# Abstract\n## Purpose\n## Methods\n## Results\n# Conclusion\n## Clinical relevance\n# Highlights\n## Integrated Multi-omics Profiling\n## Identification of a Key Cellular Subset\n## Elucidation of a Novel Mechanism\n## Strong Clinical Relevance\n# Keywords","[{\"question\":\"What is the main mechanism proposed connecting MVI to EMT in PDAC?\",\"answer\":\"In MVI⁺ tumors, ZBTB7B promotes TRIM29 transcription, and TRIM29 ubiquitinates IκBα via K48-linked modification, leading to proteasomal degradation. This activates NF-κB signaling and induces EMT, enhancing invasion and metastasis.\"},{\"question\":\"Which cell population is highlighted as important for MVI-associated EMT?\",\"answer\":\"Single-cell RNA-seq identifies a CXCL5-expressing epithelial subpopulation characterized by a strong EMT phenotype, enriched in MVI⁺ samples and positioned closer to microvessels.\"},{\"question\":\"How do TRIM29 and IκBα relate to patient prognosis in this study?\",\"answer\":\"Clinical correlation analysis shows a significant negative correlation between TRIM29 and IκBα protein levels. High TRIM29 with low IκBα and high CXCL5⁺ EMT levels associates with poor prognosis.\"}]","TRIM29 promotes pancreatic cancer - MVI via IκBα K48-ubiquitination and NF-κB activation in CXCL5⁺ epithelial cells | PDF",1790139559,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f9264d26af6636b6e3e5130b9c8fd19.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f1fc4d3af06cba8d6e003c65093b963e.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/67a066f5203b5697728ad150749b287a.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0426f6d446350a6700c46595736c5b9.webp",980,1306]